Pharmacological Modulation of Poly(ADP-ribose) Polymerase-Mediated Cell Death: Exploitation in Cancer Chemotherapy

Molecular Pharmacology

Volumn 64, Issue 5, 2003, Pages 1007-1014

  Nguewa, Paul A ^a   Fuertes, Miguel A ^b   Alonso, Carlos ^b   Peréz, José Manuel ^b  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; POLY(ADP RIBOSE)POLYMERASE 1 INHIBITOR; UNCLASSIFIED DRUG;

CANCER ADJUVANT THERAPY; CELL DEATH; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MODULATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; SHORT SURVEY;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; DNA DAMAGE; FORECASTING; HUMANS; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN CONFORMATION;

EID: 0142241246     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.5.1007     Document Type: Short Survey

References (80)

1. Al-Mohanna FA, Caddy KW, and Bolsover SR (1994) The nucleus is insulated from large cytosolic calcium ion changes. Nature (Lond) 367:745-750.
2. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, and Lipton SA (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 92:7162-7166.
3. Boulares AH, Yokovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S, and Smulson M (1999) Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 274:22932-22940.
4. Bowman KJ, White A, Golding BT, Griffin RJ, and Curtin NJ (1998) Potentiation of anti-cancer agent cytotoxicity by the potent poly(ADP-ribose) polymerase inhibitors NU1025 and NU1064. Br J Cancer 78:1269-1277.
5. Bürkle A (2001a) Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays 23:795-806.
6. Bürkle A (2001b) PARP-1: a regulator of genomic stability linked with mammalian longevity. ChemBioChem 2:725-728.
7. + precursors, nicotinic acid and nicotinamide protect cells against apoptosis induced by a multiple stress inducer, deoxycholate. Cell Death Differ 7:314-326.
8. Cuezva JM, Krajewska M, López de Heredia M, Krajewski S, Santamaría G, Kim H, Zapata JM, Marusawa H, Chamorro M, and Reed JC (2002) The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res 62:6674-6681.
9. D'Amours D, Desnoyers S, D'Silva I, and Poirier GG (1999) Poly(ADPribosyl)ation reactions in the regulation of nuclear functions. Biochem J 342:249-268.
10. D'Amours D, Sallmann FR, Dixit VM, and Poirier GG (2001) Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J Cell Sci 114:3771-3778.
11. D'Mello SR, Galli C, Ciotti T, and Calissano P (1993) Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci USA 90:10989-10993.
12. Davidovic L, Vodenicharov M, Affar EB, and Poirier GG (2001) Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Exp Cell Res 268:7-13.
13. de Murcia G and Menissier de Murcia J (1994) Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci 19:172-176.
14. de Murcia G, Schreiber V, Molinete M, Saulier B, Poch O, Masson M, Niedergang C, and Menissier de Murcia J (1994) Structure and function of Poly(ADP-ribose) polymerase. Mol Cell Biochem 138:15-24.
15. 8- dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 192:1685-1696.
16. + depletion and cell death induced by oxidative stress. J Biol Chem 278:18426-18433.
17. Eastman A (1999) The mechanism of action of cisplatin: from adducts to apoptosis, in Cisplatin, Chemistry and Biochemistry of a Leading Anticancer Drug (Bernhard Lippert ed) p 111, Wiley-VCH, Basel, Switzerland.
18. Eguchi Y, Shimizu S, and Tsujimoto Y (1997) Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 57:1835-1840.
19. Farber JL, Kyle ME, and Coleman JB (1990) Mechanisms of cell injury by activated oxygen species. Lab Invest 62:670-679.
20. Fruman DA, Meyers RE, and Cantley LC (1998) Phosphoinositide kinases. Annu Rev Biochem 67:481-507.
21. Fuertes MA, Alonso C, and Pérez JM (2003a) Biochemical modulation of cisplatin mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem 10:257-266.
22. Fuertes MA, Castilla J, Alonso C, and Pérez JM (2003b) Cisplatin biochemical mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chem Rev 103:645-663.
23. Galli C, Meucci O, Scorziello A, Werge TM, Calissano P and Schettini G (1995) Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin and IGF-I through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J Neurosci 15:1172-1179.
24. Germain M, Affar EB, D'Amours D, Dixit VM, Salvesen GS, and Poirier GG (1999) Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J Biol Chem 274:28379-28384.
25. Golstein P, Ojcius DMA, and Young JDE (1991) Cell death mechanisms and the immune system. Immunol Rev 121:29-65.
26. González VM, Fuertes MA, Alonso C, and Pérez JM (2001) Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol 59:657-663.
27. Green DR and Reed JC (1998) Mitochondria and apoptosis. Science (Wash DC) 281:1309-1312.
28. Guchelaar HJ, Vermes I, Koopmans RP, Reutelingsperger CPM, and Haanen C (1998) Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin and 5-fluorouracil in vitro: a quantitative pharmacodynamic model. Cancer Chemother Pharmacol 42:77-83.
29. Henkels KM and Turchi JJ (1997) Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines. Cancer Res 57:4488-4492.
30. Herceg Z and Wang ZQ (1999) Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis. Mol Cell Biol 19:5124-5133.
31. Homburg S, Visochek L, Moran N, Dantzer F, Priel E, Asculai E, Schwartz D, Rotter V, Dekel N, and Cohen-Armon M (2000) A fast signal-induced activation of poly(ADP-ribose) polymerase: a novel downstream target of phospholipase C. J Cell Biol 150:293-307.
32. Isola ELD, Lammel EM, and González Cappa SM (1987) Trypanosoma cruzi: differentiation to metacyclic trypomastigotes in the presence of ADP-ribosyltransferase inhibitors. Exp Parasitol 64:424-429.
33. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, and Poirier GG (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976-3985.
34. Kim JW, Kim K, Kang K, and Joe CO (2000) Inhibition of homodimerization of poly(ADP-ribose) polymerase by its C-terminal cleavage products produced during apoptosis. J Biol Chem 275:8121-8125.
35. Kupper JH, de Murcia G, and Burkle A (1990) Inhibition of poly(ADP-ribosyl)ation by overexpressing the poly(ADP-ribose)polymerase DNA-binding domain in mammalian cells. J Biol Chem 265:18721-18724.
36. Lautier D, Lagueux J, Thibodeau J, Ménard L, and Poirier GG (1993) Molecular and biochemical features of poly (ADP-ribose) metabolism. Mol Cell Biochem 122:171-193.
37. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, and Earnshaw WC (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (Lond) 371:346-347.
38. Leist M, Single B, Castoldi AF, Kühnle S, and Nicotera P (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 185:1481-1486.
39. Leist M, Single B, Naumann H, Fava E, Simon B, Kuhnle S, and Nicotera P (1999) Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis. Exp Cell Res 249:396-403.
40. Lindahl T, Satoh MS, Poirier GG, and Klungland A (1995) Post-translational modification of poly(ADP-ribose)polymerase induced by DNA strand breaks. Trends Biochem Sci 20:405-412.
41. Lowe SW and Lin AW (2000) Apoptosis in cancer. Carcinogenesis 21:485-495.
42. Marsischky GT, Wilson BA, and Collier RJ (1995) Role of glutamic acid 988 of human poly(ADP-ribose) polymerase in polymer formation. Evidence for active site similarities to the ADP-ribosylating toxins. J Biol Chem 270:3247-3255.
43. Martin DS, Stolfi RL, Sawyer RC, Spiegelman S, Casper ES, and Young CW (1983) Therapeutic utility of utilizing low doses of N-(phosphonacetyl)-L-aspartic acid in combination with 5-fluorouracil: a murine study with clinical relevance. Cancer Res 43:2317-2321.
44. Martin DS, Bertino JR, and Koutcher JA (2000) ATP depletion + pyrimidine depletion can markedly enhance cancer chemotherapy: Fresh insight for a new approach. Cancer Res 60:6776-6783.
45. Martin DS, Spriggs D, and Koutcher JA (2001) A concomitant ATP-depleting strategy markedly enhances anticancer activity. Apoptosis 6:125-131.
46. Masson M, Rolli V, Dantzer F, Trucco C, Schreiber V, Fribourg S, Molinete M, Ruf A, Alves Miranda E, Niedergang C, et al. (1995) Poly(ADP-ribose) polymerase: structure-function relationship. Biochimie 77:456-461.
47. Mendeleyev J, Kirsten E, Kaham A, Buki KG, and Kun E (1995) Potential chemotherapeutic of 4-iodo-3-nitrobenzamida. Metabolic reduction to the 3-nitroso derivatives and induction of cell death in tumor cells in culture. Biochem Pharmacol 50:705-714.
48. Miesel R, Kurpisz M, and Kroger H (1995) Modulation of inflammatory arthritis by inhibition of poly(ADP ribose) polymerase. Inflammation 19:379-387.
49. 2)]: cross-linking between d(G) and complementary d(C) within oligonucleotide duplexes. ChemBioChem 3:61-67.
50. Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, and Schmoll HJ (2003) Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Cancer Res 63:513-521.
51. Nicotera P, Leist M, and Ferrando-May E (1998) Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett 102-103:139-142.
52. Nicotera P, Leist M, and Ferrando-May E (1999) Apoptosis and necrosis: different execution of the same death. Biochem Soc Symp 66:69-73.
53. Nord LD, Stolfi RL, Alfieri AA, Netto G, Reuter V, Sternberg SS, Colofiore JR, Koutcher JA and Martin DS (1997) Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletion. Cancer Chemother Pharmacol 40:376-384.
54. Nowak AK, Lake RA, Marzo AL, Scott B, Heath WR, Collins EJ, Frelinger JA, and Robinson BWS (2003) Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells. J Immunol 170:4905-4913.
55. Orrenius S, Zhivotovsky B, and Nicotera P (2003) Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Bio 4:552-565.
56. Palomba L, Sestili P, Columbaro M, Falcieri E, and Cantoni O (1999) Apoptosis and necrosis following exposure of U937 cells to increasing concentrations of hydrogen peroxide: the effect of the poly(ADP-ribose)polymerase inhibitor 3-aminobenzamide. Biochem Pharmacol 58:1743-1750.
57. 2(isopropylamine)(amine′)] complexes. J Inorg Biochem 77:37-42.
58. Pink JJ, Planchon Sm, TAgliarino C, Varnes Me, Siegel D and Boothman DA (2000) NADP(H):quinone oxidoreductase activity is the principal determinant of β-lapachone cytotoxicity. J Biol Chem 275:5416-5424.
59. Ran Z, Rayet B, Rommelaere J, and Faisst S (1999) Parvovirus H-1-induced cell death: influence of intracellular NAD consumption on the regulation of necrosis and apoptosis. Virus Res 65:161-174.
60. Ruf A, Ménissier de Murcia J, de Murcia G, and Schulz GE (1996) Structure of the catalytic fragment of poly(ADP-ribose) polymerase from chicken. Proc Natl Acad Sci USA 93:7481-7485.
61. Ruf A, Rolli V, de Murcia G, and Schulz GE (1998) The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis. J Mol Biol 278:57-65.
62. Satoh MS, Poirier GG, and Lindahl T (1994) Dual effect for poly(ADP-ribose) synthesis in response to DNA strand breakage. Biochemistry 33:7099-7106.
63. Schimmer AD, Pedersen IM, Kitada S, Eksioglu-Demiralp E, Minden MD, Pinto R, Mah K, Andreeff M, Kim Y, Suh WS, et al. (2003) Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy. Cancer Res 63:1242-1248.
64. Shantz GD, Smith CM, Fontenella LJ, Lau HKF, and Henderson JF (1973) Inhibition of purine nucleotide metabolism by 6-methylthiopurine ribonucleoside and structurally related compounds. Cancer Res 33:2867-2871.
65. Shiobara M, Miyazaki M, Ito H, Togawa A, Nakajima N, Nomura F, Morinaga N, and Noda M (2001) Enhanced polyadenosine diphosphate-ribosylation in cirrhotic liver and carcinoma tissues in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 16:338-344.
66. Simonin F, Höfferer L, Panzeter P, L Muller S, de Murcia G and Althaus FR (1993) The carboxyl-terminal domain of human poly(ADP-ribose) polymerase. Overproduction in Escherichia coli, large scale purification and characterization. J Biol Chem 268:13454-13461.
67. Southan GJ and Szabó C (2003) Poly(ADP-ribose) polymerase inhibitors. Curr Med Chem 10:321-340.
68. Street JC, Mahmoud V, Ballon D, Alfieri AA, and Koutcher JA (1996) 13C and 31P NMR investigation of effect of 6-aminonicotinamide on metabolism of RIF-1 tumor cells in vitro. J Biol Chem 271:4113-4119.
69. Szabó E, Virag L, Bakondi E, Gyure L, Hasko G, Bai P, Hunyadi J, Gergely P, and Szabó C (2001) Peroxynitrite production, DNA breakage and poly(ADP-ribose) polymerase activation in a mouse model of oxazolone-induced contact hypersensitivity. J Invest Dermatol 117:74-80.
70. Tanizawa A, Kubota M, Hashimoto H, Shimizu T, Takimoto T, Kitoh T, Akiyama Y, and Mikama H (1989) VP-16-induced nucleotide pool changes and poly(ADP-ribose) synthesis: the role of VP-16 in interphase death. Exp Cell Res 185:237-246.
71. Tentori L, Balduzzi A, Portarena I, Levati L, Vernole P, Gold B, Bonmassar E and Graziani G (2001) Poly(ADP-ribose) polymerase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester. Cell Death Differ 8:817-828.
72. Tentori L, Portarena I, and Graziani G (2002) Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors. Pharmacol Res 45:73-85.
73. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, and Dixit VM (1995) Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801-809.
74. Toker A (1998) The synthesis and cellular roles of phosphatidylinositol 4, 5-bisphosphate. Curr Opin Cell Biol 10:254-261.
75. Vanni A, Fiore M, De Salvia R, Cundari E, Ricordy R, Ceccarelli R, and Degrassi F (1998) DNA damage and cytotoxicity induced by β-lapachone. relation to poly(ADP-ribose) polymerase inhibition. Mutat Res 401:55-63.
76. Villamil SF, Podestá D, Molina M, and Stoppani A (2001) Characterization of poly(ADP-ribose) polymerase from Crithidia fasciculata: enzyme inhibition by β-lapachone. Mol Biochem Parasitol 115:249-256.
77. Virág L and Szabó C (2002) The therapeutic potential of poly (ADP-ribose) polymerase inhibitors. Pharmacol Rev 54:375-429.
78. Weltin D, Marchal J, Dufour P, Potworowski E, Oth D, and Bischoff P (1994) Effect of 6(5H)-phenanthridinone, an inhibitor of poly(ADP-ribose) polymerase, on cultured tumor cells. Oncol Res 6:399-403.
79. Wielckens K, Garbrecht M, Kittler M, and Hilz H (1980) ADP-ribosylation of nuclear proteins in normal lymphocytes and in low-grade malignant non-Hodgkin lymphoma cells. Eur J Biochem 104:279-287.
80. Wyllie AH (1987) Apoptosis: cell death in tissue regulation. J Pathol 153:313-316.